Close Menu

NEW YORK – Antibiotic resistance testing company Accelerate Diagnostics said after the close of the market on Tuesday that its fourth quarter revenues fell 11 percent year over year.

For the three months ended Dec. 31, 2020, the company posted revenues of $3.1 million compared to $3.5 million for Q4 2019, which missed analysts' average estimate of $4.1 million.

Its fourth quarter revenues were down year over year because of an international capital deal in the fourth quarter of 2019 that did not repeat in the current year, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.